Dynamic PET CT as a Tool for Treatment Efficacy Monitoring in Lung Cancer
NCT02505685 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2016-11-18
Summary
The purpose of this study is to evaluate the use of Dynamic PET/CT as a tool to assess disease response to anti-cancer therapy in Lung Cancer patients.
Conditions
Sponsors & Collaborators
-
Rabin Medical Center
lead OTHER
Principal Investigators
-
Nir Peled, MD PhD FCCP · Rabin Medical Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 95 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-30
- Primary Completion
- 2018-07-31
- Completion
- 2020-07-31
Countries
- Israel
Study Locations
More Related Trials
-
PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers
NCT00136890 ·Status: COMPLETED ·Phase: PHASE3
-
Characterization of Methylation Patterns in Lung Cancer
NCT02373917 ·Status: COMPLETED
-
Searching for Predictive Biomarkers of Efficacy in Small Cell Lung Cancer Patients Treated With Chemotherapy-immunotherapy Combination Using Imaging Mass Cytometry (HYPE)
NCT06558903 ·Status: ACTIVE_NOT_RECRUITING
-
Pilot Study of Regional Lung Ventilation
NCT03077113 ·Status: COMPLETED ·Phase: NA
-
Randomized Study of Positron Emission Tomography - Computed Tomography (PET/CT) in Pre-Operative Staging of Lung Cancer
NCT00867412 ·Status: COMPLETED
-
Role of PET CT in Determining Target Volumes in Radiation Therapy for Lung Cancer
NCT00221169 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Radiomics for prEdiction of lunG cAncer biologY
NCT05819905 ·Status: UNKNOWN
-
Improving Pulmonary Function Following Radiation Therapy
NCT02843568 ·Status: COMPLETED ·Phase: NA
-
Clinical Application of MR-PET in Non-small Cell Lung Cancer: Diagnosis, Treatment Outcome, and Prognosis Prediction
NCT03053804 ·Status: UNKNOWN ·Phase: NA
-
Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer
NCT00603057 ·Status: COMPLETED
-
68Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLC
NCT06756217 ·Status: RECRUITING
-
Prospective Cohort Study Evaluating 18FDG PET-CT for the Early Prediction of the Efficacy of Immunotherapy Associated or Not With Chemotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Broncho-Pulmonary Carcinoma
NCT06833229 ·Status: RECRUITING
-
Whole-Body Magnetic Resonance Imaging/Positron Emission Tomography (MRI/PET) in the Staging of Non-Small-Cell Lung Cancer (NSCLC)
NCT01065415 ·Status: COMPLETED
-
CT Perfusion Scans for Assessment of Lung Cancer Before and After Chemo +/- Radiotherapy
NCT00188214 ·Status: COMPLETED ·Phase: PHASE2
-
Dynamic PET/CT Evaluated the Response of Neoadjuvant Anti-PD1 Combination With Chemotherapy for Ⅱa-Ⅲb NSCLC
NCT04586465 ·Status: UNKNOWN ·Phase: PHASE2
-
Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer
NCT02117440 ·Status: TERMINATED
-
Application of 68Ga-labeled ACE2 Targeting Probe PET/CT Imaging in Tracing ACE2 Expression and Diagnosis of Lung Cancer
NCT06194630 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Liquid Biopsy in Lung Cancer
NCT03479099 ·Status: COMPLETED
-
A Non Interventional Pilot Study on Machine Learning for ILD Detection Based on the Patient Data From Digital Devices in Unresectable Stage III Non-Small Cell Lung Cancer Patients Receiving Durvalumab
NCT04884269 ·Status: COMPLETED
-
PD-L1 PET Imaging in Patients With the Immunotherapy for Non-small Cell Lung Cancer
NCT05533086 ·Status: UNKNOWN
-
Image Discovering Early Lung Cancer Project
NCT01914458 ·Status: UNKNOWN ·Phase: PHASE2
-
Machine Learning to Construct an Association Model for Lung Cancer and Environmental Hormone
NCT06259461 ·Status: ACTIVE_NOT_RECRUITING
-
Early Detection of Lung Cancer in Czech High-risk Asymptomatic Individuals
NCT04627350 ·Status: UNKNOWN
-
Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Multicenter Study
NCT07243873 ·Status: RECRUITING
-
Pathological and Nuclear Medicine Factors for Prognosis in Lung Carcinoma
NCT04276025 ·Status: COMPLETED